Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
Paller, Amy S, Simpson, Eric L, Siegfried, Elaine C, Cork, Michael J, Wollenberg, Andreas, Arkwright, Peter D, Soong, Weily, Gonzalez, Mercedes E, Schneider, Lynda C, Sidbury, Robert, Lockshin, Benjamin, Meltzer, Steven, Wang, Zhixiao, Mannent, Leda P, Amin, Nikhil, Sun, Yiping, Laws, Elizabeth, Akinlade, Bolanle, Dillon, Myles, Kosloski, Matthew P, Kamal, Mohamed A, Dubost-Brama, Ariane, Patel, Naimish, Weinreich, David M, Yancopoulos, George D, O’Malley, John T, Bansal, Ashish, Pepper, Amber, Cohen, David, Pariser, David, Leflein, Jeffrey, Weinberg, Jeffrey, Browning, John, Teng, Joyce, Wine Lee, Lara, Sher, Lawrence, Diaz, Lucia, Schneider, Lynda, Rupp, Ned, Ong, Peck, Cartwright, Robert, Pinter, Andreas, Schnopp, Christina, Korkosz, Anna, Bystrzanowska, Dorota, Sygula, Ewa, Zdybski, Jacek, Padlewska, Kamila
Published in The Lancet (British edition) (17.09.2022)
Published in The Lancet (British edition) (17.09.2022)
Get full text
Journal Article